If you’ve spent any time studying value investing, you’ve encountered intrinsic value—the idea that every stock has an underlying worth independent of its market price. Warren Buffett built his fortune on this principle, and Benjamin Graham codified it decades before that. Actually calculating it, though, remains one of the most challenging practical skills in investing. Most investors understand the concept intellectually but stumble when they try to put numbers to it.
This guide fills that gap. I’ll walk you through three legitimate methods for calculating intrinsic value, show you real numerical examples for each, and be honest about where each approach falls short. By the end, you’ll have a working framework you can apply to actual securities—not just theory, but calculation.
What Intrinsic Value Actually Means
Intrinsic value is the present worth of all future cash flows a business will generate, discounted back to today. It’s what a rational buyer would pay for the entire business if they had the cash and could operate it indefinitely. The market price, by contrast, reflects what investors collectively believe the company is worth at this moment—and that belief can be wildly disconnected from reality, sometimes for years.
This disconnect is exactly what value investors exploit. When market price falls below intrinsic value, you have what Graham called a “margin of safety”—a cushion that protects your investment even if your estimate proves slightly wrong. The entire game revolves around estimating intrinsic value accurately enough to find these discrepancies.
Here’s the uncomfortable truth most guides don’t mention: intrinsic value is an estimate, not a fact. Two competent analysts looking at the same company can arrive at substantially different intrinsic values because they make different assumptions about growth rates, discount rates, and terminal values. Your job isn’t to find the single “correct” number—it’s to develop a reasonable range and buy only when the market price sits well below that range’s floor.
The Three Main Approaches to Intrinsic Value
Before diving into calculations, you need to understand your options. There isn’t a single “right” method; different approaches suit different business types and investor preferences.
The discounted cash flow (DCF) method projects future cash flows and discounts them back to present value. This is the most theoretically sound approach because it rests on cash—the one number that can’t be manipulated through accounting choices. However, it requires making long-term projections about businesses that may change dramatically.
The relative valuation method compares the target company to similar businesses using valuation multiples like price-to-earnings, price-to-book, or enterprise value to EBITDA. This approach works well when comparable companies exist and the market is pricing them reasonably. It breaks down when no true comparables exist or when the entire sector is mispriced.
The book value method calculates what the company would be worth if liquidated—total assets minus total liabilities. This approach makes sense for asset-heavy businesses like banks, insurers, and certain industrial companies but vastly understates the value of companies whose value resides in intangible assets like software, brands, or network effects.
I’ll cover each method in detail below, including where it works and where it falls apart.
Discounted Cash Flow
The DCF method is the backbone of professional equity analysis. Here’s how it works in practice.
First, you project free cash flow for a specific forecast period—typically five to ten years. Free cash flow represents cash generated by operations after capital expenditures, the actual money available for distribution to shareholders. Then you calculate a terminal value representing all cash flows beyond your forecast period, assuming the business continues in perpetuity at a sustainable growth rate. Finally, you discount both the projected cash flows and terminal value back to present value using an appropriate discount rate.
Let me walk through a simplified example. Suppose Company XYZ generates $100 million in free cash flow this year, grows at 8% for the next five years, then settles into 3% perpetual growth. You determine that a 10% discount rate appropriately reflects the risk.
Year 1: $100M × 1.08 = $108M → Present value: $108M ÷ 1.10 = $98.2M
Year 2: $108M × 1.08 = $116.6M → Present value: $116.6M ÷ 1.10² = $96.5M
Year 3: $116.6M × 1.08 = $125.9M → Present value: $125.9M ÷ 1.10³ = $94.7M
Year 4: $125.9M × 1.08 = $136M → Present value: $136M ÷ 1.10⁴ = $93.1M
Year 5: $136M × 1.08 = $146.9M → Present value: $146.9M ÷ 1.10⁵ = $91.3M
Sum of present values for five years: $473.8M
Now calculate terminal value. The Year 5 cash flow of $146.9M grows to $151.3M in Year 6 ($146.9M × 1.03). Terminal value = $151.3M ÷ (0.10 – 0.03) = $2.16 billion. Discount this back five years: $2.16B ÷ 1.10⁵ = $1.34 billion.
Total intrinsic value: $473.8M + $1.34B = $1.81 billion. Divide by shares outstanding to get per-share intrinsic value.
The obvious problem here is that every input involves judgment calls. Get the growth rate wrong by a couple percentage points, and your intrinsic value shifts dramatically. The terminal value often represents 60-80% of the total DCF value, meaning your assumption about long-term growth has an outsized impact. This is why I always run sensitivity analysis—calculating intrinsic value under multiple scenarios rather than relying on a single forecast.
DCF works best for stable, predictable businesses with clear cash flow generation. Using it for high-growth startups or cyclical companies produces garbage outputs regardless of how elegant your spreadsheet appears.
Relative Valuation
The relative valuation approach estimates intrinsic value by examining what the market currently pays for similar businesses. If comparable companies trade at 15 times earnings and your target earns $10 per share, a rough estimate suggests $150 per share as fair value.
The critical choice is which multiple to use. Price-to-earnings works well for profitable growth companies. Price-to-book suits asset-heavy businesses. Enterprise value to EBITDA controls for differences in capital structure. Sales multiples fit high-growth companies that aren’t yet profitable. You match the multiple to the business type.
Here’s a practical example. Consider a regional bank trading at $40 per share with book value of $25 per share and earnings of $3 per share. Comparable regional banks trade at an average of 1.5 times book and 12 times earnings.
Relative value by book: $25 × 1.5 = $37.50 per share
Relative value by earnings: $3 × 12 = $36.00 per share
The implied intrinsic value sits around $36-38 per share. Since the current price is $40, this suggests modest overvaluation.
The major weakness of relative valuation is that it assumes the market has priced comparables correctly. During the 1999 tech bubble, relative valuation told you that expensive tech stocks were fairly priced because other expensive tech stocks existed at similar multiples. It provided no warning. Similarly, in deep value markets, relative valuation can make cheap stocks look even cheaper by comparing them to other depressed companies.
Use this method to triangulate your estimate, not as your primary valuation tool. It works best as a sanity check—if DCF suggests $50 per share but relative valuation suggests $25, you need to understand why the gap exists before committing capital.
Book Value and Asset-Based Valuation
The book value method calculates what shareholders would receive if the company liquidated today, paying off all debts and distributing remaining assets. You take total assets minus total liabilities, then divide by shares outstanding.
Tangible book value refines this further by removing intangible assets like goodwill from acquired companies. If Company ABC has $1 billion in total assets, $600 million in liabilities, and $100 million in goodwill, tangible book value equals $300 million ($1B – $600M – $100M).
This approach seems outdated in an era where technology companies dominate markets, but it remains relevant for certain sectors. Banks and insurance companies carry large asset portfolios that can be valued relatively reliably. Real estate investment trusts own properties with observable market values. Industrial companies maintain equipment and inventory with assessable liquidation values.
For a software company or consumer brand business, book value grossly understates intrinsic value. The company’s actual value comes from brand relationships, proprietary technology, and organizational capabilities—assets that don’t appear on balance sheets. Using book value for these businesses would cause you to miss every great investment of the past thirty years.
A more sophisticated version, the net current asset value (NCAV) approach, was popularized by Benjamin Graham. Calculate net current assets (current assets minus total liabilities), then compare this to market capitalization. Graham suggested that stocks trading below NCAV offered exceptional margin of safety because shareholders could theoretically liquidate current assets, pay off all debts, and still own the long-term assets for free. This approach worked better in earlier eras when more companies maintained conservative balance sheets.
Mistakes That Destroy Valuation Accuracy
I’ve watched investors make the same errors repeatedly when calculating intrinsic value. Avoiding these will immediately improve your analysis.
The first mistake is relying on accounting earnings rather than cash flow. Companies can manipulate earnings through aggressive revenue recognition, deferring expenses, or aggressive assumptions about useful asset lives. Cash flow is harder to manipulate because it tracks actual money moving through the business. Always prefer free cash flow to net income in your DCF calculations.
The second mistake is using a single-point estimate instead of a range. Your intrinsic value estimate has uncertainty built into every assumption. Presenting a single number implies false precision. Instead, calculate intrinsic value under pessimistic, base, and optimistic scenarios. The gap between pessimistic and optimistic often tells you more about investment risk than the base case estimate.
The third mistake is confusing growth with value. Companies can’t grow forever—their growth rate must eventually converge with economic growth or decline as they mature. Terminal growth rates above 3-4% are rarely justified for mature economies. Using aggressive terminal growth inflates intrinsic value dramatically and leads to overpaying for “growth” stocks masquerading as value investments.
The fourth mistake is ignoring competitive threats. Your five-year cash flow projection assumes the company maintains its current competitive position. In reality, competitors, technological disruption, and regulatory changes can destroy moats quickly. Factor this risk into your discount rate or shorten your explicit forecast period.
Building Your Own Framework
Let me synthesize everything into a step-by-step process you can apply immediately.
Step 1: Understand the business. Can you explain how the company makes money in two minutes? If not, you can’t value it. Read the most recent 10-K, understand revenue streams, cost structure, and competitive positioning.
Step 2: Choose your primary method. Stable, cash-generating businesses suit DCF. Asset-heavy companies with reliable book values work with book value analysis. Everything else requires careful relative valuation or accepting that traditional intrinsic value estimates may not apply.
Step 3: Make conservative assumptions. Professional analysts tend to project optimistically because they want to justify buy ratings. Your margin of safety comes from assuming less growth, higher discount rates, and shorter competitive advantages than consensus estimates.
Step 4: Run sensitivity analysis. Test your valuation under different growth rates, discount rates, and terminal value assumptions. Know what price you’d pay under pessimistic assumptions—that’s your real risk.
Step 5: Wait for the margin of safety. Even if your intrinsic value estimate is $50 per share, don’t buy at $45. Wait for $35 or lower. The margin of safety is what protects you from being wrong.
Frequently Asked Questions
Which method produces the most accurate intrinsic value?
The DCF method is theoretically superior because it relies on actual cash flows rather than market comparisons or accounting artifacts. However, accuracy depends entirely on input quality. A well-constructed relative valuation for a stable business often beats a poorly-constructed DCF.
How do I determine the right discount rate?
The discount rate should reflect the risk of the cash flows. Use the company’s weighted average cost of capital as a starting point, then adjust upward for business-specific risks like competitive threats, regulatory exposure, or management uncertainty. Higher risk demands higher discount rates.
What if the company doesn’t pay dividends?
Many successful companies reinvest all cash flow rather than paying dividends. DCF handles this naturally—you project free cash flow regardless of distribution policy. For relative valuation, use free cash flow metrics instead of dividend-based metrics.
How often should I recalculate intrinsic value?
Recalculate whenever material new information emerges—quarterly earnings, major corporate developments, or significant market changes. However, don’t adjust too frequently based on short-term fluctuations. Intrinsic value changes slowly; daily price movements mostly reflect sentiment shifts.
Is intrinsic value relevant for growth stocks?
Traditional intrinsic value calculations struggle with high-growth companies because small percentage changes in growth assumptions produce massive changes in terminal value. For unprofitable growth companies, consider valuing based on potential market size and probability of success rather than discounted cash flows.
The Honest Assessment
Calculating intrinsic value remains more art than science. The methods I’ve described provide frameworks for organizing your thinking, not final answers. Your goal isn’t precision—it’s developing a reasonable estimate that lets you identify securities trading significantly below your range of fair value.
The real skill isn’t mathematical competence; it’s business judgment. Understanding which assumptions matter, recognizing where your analysis could go wrong, and maintaining the discipline to wait for adequate margins of safety—these are the attributes that separate successful value investors from those who lose money following formulas.
Start with simple businesses you understand deeply. Practice your calculations. Track your predictions against actual outcomes over time. Adjust your assumptions based on what actually happens. This iterative process, not any single formula, builds genuine valuation competence.
